| Manufacturer: Vivacy Active Substance(s): HYALURONIC ACID, LIDOCAINE, MANNITOL Strength: 18.5mg/g HA, 3mg/ml Lidocaine Pack Size: 1 x 1ml Pre-Filled Syringes, 2 x 30 G ½ Needles Accessories: Package insert, 2-30G 1/2 Other Known Names: STYLAGE® Special Lips w/Lido (1×1 milliliter) Stylage Special Lips Lidocaine has been specifically designed to enhance the lips, creating subtle fullness and correcting lip contours. Use Stylage Special Lips Lidocaine for correction of a disproportionate upper or lower lip size, reducing perioral lines or smoker’s lines above the upper lip and restoring lip hydration. Contains lidocaine, a powerful anaesthetic, for a more comfortable injection.Increases the volume of the lips and the enhancement of the lip border. |
Dermal Fillers
Stylage® Special Lips with Lidocaine
Price range: $104.00 through $109.00
Stylage Special Lips (with Lidocaine) is a dermal filler that focuses on lip augmentation, targeting specific lip concerns. Stylage Special Lips (with Lidocaine) has been formulated to help address lack of lip volume, definition and balance to the lips. With the addition of mannitol, in addition to being a strong antioxidant, ensures a long-lasting effect whilst reducing redness and irritation.
| Quantity | 1-5, 6-10, 11-20, 21+ |
|---|
Related products
-
Best Sellers
Radiesse® 1.5 ml
Price range: $225.00 through $245.00 Select options This product has multiple variants. The options may be chosen on the product page -
Dermal Fillers
Juvéderm® Volite with Lidocaine
Price range: $339.00 through $359.00 Select options This product has multiple variants. The options may be chosen on the product page -
Dermal Fillers
Restylane® Skinboosters™ Vital Light w/ Lidocaine
Price range: $118.00 through $139.00 Select options This product has multiple variants. The options may be chosen on the product page -
Dermal Fillers
Sculptra® 2 vials
Price range: $529.00 through $549.00 Select options This product has multiple variants. The options may be chosen on the product page
Reviews
There are no reviews yet.